Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999044 | Surgical Oncology Clinics of North America | 2008 | 12 Pages |
Abstract
The pharmacokinetic results of this study indicate that there is significant enhancement of pelvic drug levels with isolated pelvic perfusion, with the potential of increasing the therapeutic index and clinical efficacy. This system would seem to be ideal for evaluating fast-acting and highly toxic experimental drugs on human pelvic cancers having treatment protocols of limited clinical success. Pharmacokinetic modeling using empiric approximations for the kinetic rate constants is a convenient and novel way of fitting data using relatively simple mathematics and commercially available spreadsheets.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
James F. Belliveau, Harold J. Wanebo,